Steven M Greenberg Selected Research

Siderosis

12/2020	Neuropathological correlates of cortical superficial siderosis in cerebral amyloid angiopathy.
1/2020	Combining Imaging and Genetics to Predict Recurrence of Anticoagulation-Associated Intracerebral Hemorrhage.
1/2019	APOE and cortical superficial siderosis in CAA: Meta-analysis and potential mechanisms.
1/2018	Dementia incidence and predictors in cerebral amyloid angiopathy patients without intracerebral hemorrhage.
1/2016	Total Magnetic Resonance Imaging Burden of Small Vessel Disease in Cerebral Amyloid Angiopathy: An Imaging-Pathologic Study of Concept Validation.
3/2015	Cerebral amyloid angiopathy with and without hemorrhage: evidence for different disease phenotypes.
7/2011	Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer's Association Research Roundtable Workgroup.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Steven M Greenberg Research Topics

Disease

77	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 10/2022 - 01/2002
59	Cerebral Hemorrhage 01/2022 - 09/2002
29	Hemorrhage 01/2021 - 04/2004
26	Alzheimer Disease (Alzheimer's Disease) 10/2022 - 01/2006
18	Hematoma 01/2019 - 12/2005
17	Stroke (Strokes) 01/2022 - 09/2005
16	Dementia (Dementias) 01/2022 - 01/2002
13	Cognitive Dysfunction 10/2022 - 11/2004
12	Hemorrhagic Stroke 01/2021 - 01/2002
9	Ischemic Stroke 01/2022 - 07/2008
9	Familial Cerebral Amyloid Angiopathy 04/2020 - 07/2008
8	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2021 - 05/2011
7	Cerebral Small Vessel Diseases 01/2022 - 10/2016
7	Siderosis 12/2020 - 07/2011
7	Atrial Fibrillation 11/2018 - 07/2003
6	Brain Injuries (Brain Injury) 01/2022 - 11/2013
6	Disease Progression 01/2021 - 08/2011
6	Amyloid Plaque 01/2021 - 07/2005
6	Inflammation (Inflammations) 10/2017 - 02/2004
5	Hypertension (High Blood Pressure) 01/2022 - 12/2011
5	Edema (Dropsy) 04/2019 - 12/2005
3	Leukoencephalopathies 01/2022 - 04/2013
3	App-Related Cerebroarterial Amyloidosis 01/2022 - 10/2019
3	Rupture 01/2021 - 01/2009
3	Leukoaraiosis 01/2018 - 04/2013
3	Amyloid angiopathy 01/2017 - 03/2003
3	Diabetes Mellitus 01/2014 - 04/2004
3	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2012 - 11/2004
3	Heart Failure 02/2009 - 10/2006
2	Vascular Diseases (Vascular Disease) 12/2020 - 07/2005
2	Thromboembolism 01/2020 - 12/2008
2	Embolic Stroke 11/2018 - 04/2004
2	Atrophy 01/2018 - 01/2016
2	Amyloidosis 02/2017 - 09/2008
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2021
1	Cavernous Hemangioma (Cavernous Angioma) 01/2021
1	Neurologic Manifestations (Neurological Manifestations) 01/2021
1	Metabolic Diseases (Metabolic Disease) 12/2020
1	Proteostasis Deficiencies 12/2020
1	Aphasia (Dysphasia) 04/2019
1	Subdural Hematoma (Subdural Hemorrhage) 04/2019
1	Neurobehavioral Manifestations 01/2018
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2018
1	Lacunar Stroke 10/2017
1	Diffuse Axonal Injury 10/2017
1	Genetic Risk Score 10/2017

Drug/Important Bio-Agent (IBA)

52	Amyloid (Amyloid Fibrils)IBA 01/2022 - 01/2002
26	Biomarkers (Surrogate Marker)IBA 10/2022 - 08/2009
19	Amyloid beta-PeptidesIBA 03/2021 - 01/2002
19	Warfarin (Coumadin)FDA LinkGeneric 01/2019 - 07/2003
16	Apolipoproteins E (ApoE)IBA 12/2021 - 12/2010
12	Biological ProductsIBA 01/2022 - 09/2002
9	ApolipoproteinsIBA 08/2020 - 06/2012
9	Peptides (Polypeptides)IBA 01/2020 - 01/2002
9	AnticoagulantsIBA 01/2017 - 07/2003
8	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2002
7	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 08/2015 - 06/2008
6	Antihypertensive Agents (Antihypertensives)IBA 01/2020 - 12/2005
5	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 10/2019 - 11/2008
4	IronIBA 01/2022 - 01/2018
4	LipidsIBA 08/2016 - 01/2014
4	Matrix Metalloproteinases (MMPs)IBA 11/2015 - 12/2005
4	Hemostatics (Antihemorrhagics)IBA 11/2014 - 08/2008
3	CholesterolIBA 01/2021 - 06/2008
3	DNA (Deoxyribonucleic Acid)IBA 02/2017 - 09/2009
3	HemosiderinIBA 01/2014 - 07/2011
2	CalciumIBA 01/2022 - 11/2016
2	Glucose-6-Phosphate Isomerase (Phosphoglucose Isomerase)IBA 11/2021 - 01/2021
2	Nerve Growth Factors (Neurotrophins)IBA 11/2021 - 01/2021
2	CreatinineIBA 01/2021 - 01/2018
2	FibrinIBA 01/2021 - 01/2019
2	Hemoglobins (Hemoglobin)IBA 01/2021 - 01/2019
2	Dabigatran FDA Link 01/2019 - 01/2011
2	HDL CholesterolIBA 11/2016 - 01/2014
2	Genetic Markers (Genetic Marker)IBA 10/2016 - 12/2008
2	Matrix Metalloproteinase 9 (Gelatinase B)IBA 06/2015 - 09/2006
2	Pharmaceutical PreparationsIBA 06/2015 - 10/2006
2	recombinant FVIIa (rFVIIa)FDA Link 01/2013 - 09/2006
2	Collagen Type IV (Type IV Collagen)IBA 04/2012 - 07/2008
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2011 - 11/2004
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 01/2022
1	Plasminogen Activators (Plasminogen Activator)IBA 01/2022
1	Antidepressive Agents (Antidepressants)IBA 01/2022
1	AN-1792IBA 01/2022
1	Waste Products (Waste Product)IBA 01/2022
1	aducanumabIBA 01/2021
1	Triglycerides (Triacylglycerol)IBA 01/2021
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 08/2020
1	ponezumabIBA 04/2019
1	PolymersIBA 01/2019
1	estropipate (Ogen)FDA LinkGeneric 01/2019
1	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 01/2019
1	Evans Blue (Blue, Evans)FDA Link 01/2019
1	Labetalol (Normodyne)FDA LinkGeneric 01/2019
1	Formaldehyde (Formol)FDA Link 01/2018
1	Pemetrexed (MTA)FDA Link 01/2018

Therapy/Procedure

24	Therapeutics 01/2022 - 07/2003
4	Immunotherapy 01/2022 - 02/2007
3	Secondary Prevention 08/2015 - 05/2011
1	Off-Label Use 01/2021